PAVmed Inc (PAVM) is a Healthcare · Medical Devices company listed on NASDAQ. Price $3.96 (-0.25%), Market cap $0.05B, 52-week low–high $0.22 ~ $12.05.
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay perform
Financial statements, price targets, institutional (13F) holdings and related news for PAVmed Inc are updated in real time on BlackAll Trade.
PAVmed Inc trades at $3.96 (-0.25%). Real-time quotes and charts are available on BlackAll Trade.
PAVmed Inc has a market cap of about $0.05B.
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, dispos